Company snapshot
Market Cap
$31B
Large-cap2016 — today
10-Year Price
+51%
2016 — today
52-Week Range
$71.86$150.61
Current $72.86· 1%
Featured in rankings
S&P500Most Undervalued Healthcare StocksBest Healthcare Dividend StocksBest Healthcare GARP StocksMost Undervalued Value StocksMost Undervalued Dividend StocksMost Undervalued Growth Stocks
Rankings recomputed after each US market close — see where ZTS stands against peers.
Similar companies
| Company | P/E | Div yield |
|---|---|---|
| ALCAlcon Inc. | 51.2 | 0.5% |
| CNCCentene Corporation | -6.3 | — |
| ALNYAlnylam Pharmaceuticals, Inc. | 41.8 | — |
| AAgilent Technologies, Inc. | 28.2 | 0.5% |
| ONCBeOne Medicines Ltd. | 4.9 | — |
| IDXXIDEXX Laboratories, Inc. | 35.9 | — |
| TEVATeva Pharmaceutical Industries Limited | 61.4 | — |
| RVMDRevolution Medicines, Inc. | -23.4 | — |
Healthcare companies of comparable size — each one shown against its own 10-year range, not a sector average. Browse all stocks we cover.
Valuation in context
P/E ratio
12.1
Near historic low
Near historic low — last 10 years
Sector median 25.0below sector
P/B ratio
9.6
Near historic low
Near historic low — last 10 years
Sector median 2.5above sector
EV / EBITDA
9.5
Near historic low
Near historic low — last 10 years
Sector median 15.3below sector
Dividend Yield
2.8%
Near historic high
Near historic highs — last 10 years
Sector median 1.7%above sector
PEG ratio
1.2
Near historic low
Near historic low — last 10 years
Sector median 1.5below sector
FCF Yield
6.9%
Near historic high
Near historic highs — last 10 years
Sector median -9.8%above sector